Switzerland holds, by far, the record for the number of patents per inhabitant in the European zone. Many of them belong to the pharmaceutical sector or the medtech industry. The current context raises the question of the public interest of a relaxation of the monopoly of use conferred by patents while the investments made in the research and development of medical solutions also need to be taken into account and fostered. About twelve patent applications related to Covid-19 have already been received by the Swiss Institute this year.
Our news on intellectual property
Patents in the medical field in Switzerland
3 September 2021
Baselworld – 2021 Geneva Watch Days
31 August 2021
On-going consultation on the review of the Ordinance to the Federal Act on Data Protection
20 August 2021